I'm LongbridgeAI, I can summarize articles.Bumble (BMBL) surged 56% after agreeing to a $1.3 billion all-cash acquisition by Ithaca Holdings, taking the company private at $6.05 per share. Conversely, Cipher Digital (CIFR) dropped 14.8% following an $850 million convertible note offering proposal and a Morgan Stanley price target cut. Hims & Hers Health (HIMS) fell 1.4% amid rumors regarding temporary allowances for banned peptides.
Mixed sentiment is driving markets in both directions today, with the Dow Jones Industrial Average (DJI) as much as nearly 500 points higher this morning. Below, we'll take a closer look at several names making noise on Wall Street today.
Dating App Lands Billion-Dollar Acquisition
- Bumble Inc (NASDAQ:BMBL) is trading 56% higher after agreeing to be acquired and taken private by Ithaca Holdings in an all-cash deal worth $1.3 billion, or $6.05 per share.
- BMBL is trading at five-month highs in response, now sporting a 66.4% year-to-date lead.
Drug Stock Climbs on Heels of Bull Note
- Cipher Digital Inc (NASDAQ:CIFR) is gapping 14.8% lower this afternoon, after the hyperscaler proposed an $850 million convertible note offering. The equity also suffered a price-target cut to $51.50 from $54 at Morgan Stanley last night.
- CIFR is headed for its lowest close since September 2025 and has already shed 25% in 2026. Today will mark a 12th loss in 15 sessions for the stock.
Peptide Rumors Trigger HIMS Stock Slide
- Hims &Hers Health Inc (NYSE:HIMS) is trading 1.4% lower at last glance, after rumors surfaced that there may be a temporary allowance to currently banned peptides, though some investors are bracing for continued rejection from recent chart resistance.
- HIMS has been consolidating below $32 since August, despite multiple breakout attempts. Year to date, the stock has shed 7.4%.